phamaceutical giant

The Swiss phamaceutical giant Novartis AG (NYSE: NVS) engaged in the research, development, manufacture and marketing of healthcare products reported, its Q3 net income totaled $2.11 billion compared with $2.08 billion in the same period a year ago. Its net sales totaled $11.08 billion from $10.74...